Q4FY25 Revenue from operations at INR 11,974 Mn up 2% YoY, EBITDA at INR 2,524 Mn down 1% YoY, PAT at INR 1,520 Mn up 17% YoY
Mumbai, India, May 28, 2025: Granules India Ltd., a vertically integrated pharmaceutical company, today announced its financial results for the quarter and financial year ended March 31, 2025. QUARTERLY CONSOLIDATED FINANCIALS Q4FY25 Q3FY25 Growth (QoQ)…